In the news

Nature reviews the Cell publication

Longevity Technology writes about Atrogi’s latests results

Cell paper highlighting transformative potential of muscle-targeted therapy in metabolic disease

Atrogi participates in EASD Annual meeting

New patent granted

BIO-Europe 2017 in Berlin

Second patent granted

5MSEK fund granted

First patent granted